ONKURE THERAPEUTICS INC
OKUR·68277Q105·US·Common Stock·Healthcare - Biotechnology-Activist
OKUR (ONKURE THERAPEUTICS INC) is held by 29 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($16.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($5M), VANGUARD CAPITAL MANAGEMENT LLC ($2.4M). Net institutional sentiment: Mixed.
29
Holders
Avg rating(6 Elite)
$29.2M
Total Value
58% (34)
Fund Consensus
18 buying - 13 selling
Who's Trading
InsiderLALeverone Jason A.Sell $1KJun 22, 2026
ActivistBLBVF PARTNERS L P/IL5.3%May 27, 2026
ActivistADADAR1 Capital Management, LLC6.0%May 15, 2026
ActivistTETrails Edge Capital Partners, LP6.0%Apr 7, 2026
ActivistSTStepStone Group LP6.6%Apr 7, 2026
ActivistABAI Biotechnology LLC20.0%Apr 7, 2026
InsiderLALeverone Jason A.Sell $1KMar 23, 2026
InsiderSASaccomano Nicholas ASell $357.46Mar 23, 2026
InsiderLALeverone Jason A.Sell $896.25Dec 22, 2025
13F: Insider & Congress:
Showing 1-20 of 34
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer